ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

DWTX vs ATNM // PIOTROSKI F-SCORE QUALITY

Dogwood Therapeutics Inc. (NASDAQ) VS. Actinium Pharmaceuticals Inc. (Delaware) (NYSE) • 15-METRIC TALLY: DWTX 2 — ATNM 2
▲ PIOTROSKI F-SCORE QUALITY LEADER: ATNM
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DWTX VS. ATNM) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC DWTX ATNM SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -32.30% -35.00% +2.70 DWTX /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin — -60.00% — TIE /operating-margins <GO>
Net Profit Margin — -60.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality ACTIVE 2/9 3/9 -1.00 ATNM /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 40.9 56.3 -15.40 ATNM /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $46.6M $45.0M $1.7M DWTX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR DWTX REV ATNM REV DWTX GROSS % ATNM GROSS % DWTX FCF ATNM FCF
FY 2025 $78.3M $90.0K — — -$15.6M -$24.7M
FY 2024 $34.2M $117.9M — — -$8.8M -$33.1M
FY 2023 $15.3M $81.0K — — -$4.9M -$47.3M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DWTX // BETA —
ATNM // BETA —